Abstract
Canada represents one of the largest markets for pharmaceuticals in the world,
with a huge potential for generics. In 2008, generics accounted for more than
51% prescriptions and around 23% sales of the total pharmaceutical market. The
Canadian generics market is benefitting from several factors such as rapidly
ageing population, patent expiry of several blockbuster drugs, lower costs and
cost containment measures by the government.
According to our latest market research report, "Generic Drug Market in
Canada", low cost of generics and billion dollar drug patent expiries will
enable the generics market to continue its double-digit growth in the next
five years. Moreover, the current economic slowdown will also add to the
growth in sales of generics in the country.
Our report has identified that at present, drugs to treat chronic diseases
account for most of the pharmaceutical market, with cardiovascular drugs
holding the top spot. However in future, strong growth is expected in other
chronic segments, particularly in cancer and diabetes which will further drive
the market to maintain its growth pace.
The report provides thorough analysis of the factors that distinguish Canada
from other generics markets both in positive and negative ways. A major factor
that differentiates the Canadian generics market from the US and most European
markets, for instance, is comparatively higher prices of generics and lower
price erosion. As this characteristic of the market allows manufacturers to
fetch better margins from their drugs, many foreign players have shown keen
interest to enter the Canadian generics market to make most of this lucrative
characteristic.
"Generic Drug Market in Canada" provides extensive research and objective
analysis of the generic drug market in Canada. The report thoroughly evaluates
the current market trends and relates them with past trends to give future
growth prospects of various segments of the Canadian generic drug market. The
report examines the performance of various players in the Canadian
pharmaceutical and generic markets. Besides, a number of factors which can
deteriorate the future market growth have also been discussed in the report.
Table of Contents
1. Analyst View
2. Macroeconomic and Healthcare Factors
- 2.1 Macroeconomic Indicators
- 2.2 Population Profile
- 2.3 Age Profile
- 2.4 Healthcare Spending and Infrastructure
3. Pharmaceutical Market
- 3.1 Market Size and Growth
- 3.1.1 Prescriptions
- 3.1.2 Sales
- 3.2 By Therapeutic Category
- 3.3 By Drug Category
- 3.4 Healthcare Expenditure
- 3.5 Top Selling Drugs
- 3.5.1 Prescriptions
- 3.5.2 Sales
4. Generics Market Attractions
- 4.1 Favorable Political Environment
- 4.2 Aging Population
- 4.3 Patent Expiration
- 4.4 High Returns for Pharmacists
- 4.5 Huge Cost Savings
5. Generics Market
- 5.1 Market Size and Growth
- 5.1.1 Prescriptions
- 5.1.2 Sales
- 5.2 By Province/Territories
- 5.2.1 Drug Consumption
- 5.2.2 Prescriptions
- 5.2.3 Sales
- 5.3 Market Segmentation
- 5.3.1 Retail Pharmacies
- 5.3.2 Hospital Pharmacies
- 5.3.3 Authorized and Independent Generics
- 5.3.4 Distribution Channels
6. Generics Market - Opportunity Areas
- 6.1 Cardiovascular Drugs
- 6.2 Psychotherapeutics
- 6.3 Cholesterol Agents
- 6.4 Antidiabetics
7. Forecast for Branded and Generic Drug to 2013
8. Key Players
- 8.1 Pharmaceutical Market
- 8.1.1 Prescriptions
- 8.1.2 Sales
- 8.2 Generics Market
- 8.2.1 Prescriptions
- 8.2.2 Sales
- 8.2.3 Retail Pharmacies
- 8.2.4 Hospital Pharmacies
9. General Approval Process
- 9.1 Abbreviated New Drug Submission
- 9.2 Notice of Allegation
10. Industry Roadblock
- 10.1 Extension of Data Exclusivity
- 10.2 Ever-greening of Drug Patents
- 10.3 Authorized Generics
List of Figures:
- Figure 2-1: Nominal GDP (Billion US$), 2002-2008
- Figure 2-2: Consumer Price Index (%), 2002-2008
- Figure 2-3: Forecast for Consumer Price Index (%), 2009-2013
- Figure 2-4: Currency Exchange Rate (From CAD to US$), 2002-2008
- Figure 2-5: Population (Million), 2002-2008
- Figure 2-6: Forecast for Population (Million), 2009-2013
- Figure 2-7: Life Expectancy (Years), 2002-2008
- Figure 2-8: Forecast for Life Expectancy (Years), 2009-2013
- Figure 2-9: Population Breakup by Age Group (%), 2002-2008
- Figure 2-10: Forecast for Population Breakup by Age Group (%), 2009-2013
- Figure 2-11: Per Head Healthcare Spending (US$), 2002-2008
- Figure 2-12: Forecast for Per Head Healthcare Spending (US$), 2009-2013
- Figure 2-13: Number of Doctors (per ' 000 Population), 2002-2008
- Figure 2-14: Forecast for Number of Doctors (2009-2013)
- Figure 2-15: Number of Hospital Beds (per ' 000 Population), 2002-2008
- Figure 2-16: Forecast for Number of Hospital Beds (per ' 000 Population),
2009-2013
- Figure 3-1: Prescriptions Dispensed in Pharmaceutical Market (Million),
2007 & 2008
- Figure 3-2: Pharmaceutical Sales (Billion CAD), 2005-2008
- Figure 3-3: Pharmaceutical Purchases by Retail and Hospital Pharmacies
(Billion CAD), 2005-2008
- Figure 3-4: Deaths by Various Causes (%), 2005 & 2008
- Figure 3-5: Share of Generic and Branded Drug by Prescription (2008)
- Figure 3-6: Share of Generic and Branded Drug by Sales (2008)
- Figure 3-7: Drug Financing by Source (%), 2008
- Figure 4-1: Population above 65 Years of Age (Million), 2002-2008
- Figure 4-2: Average Cost of Branded and Generic Drug (CAD), 2002-2008
- Figure 5-1: Prescriptions Dispensed in Branded Drug Market (Million),
2002-2008
- Figure 5-2: Prescriptions Dispensed in Generic Drug Market (Million),
2002-2008
- Figure 5-3: Share of Generic and Branded Drug by Prescription (2002-2008)
- Figure 5-4: Generic Drug Sales (Billion CAD), 2002-2008
- Figure 5-5: Branded Drug Sales (Billion CAD), 2002-2008
- Figure 5-6: Share of Generic and Branded Drug by Sales (2002-2008)
- Figure 5-7: Branded Drug Sales through Retail Pharmacies (Billion CAD),
2005-2008
- Figure 5-8: Generic Drug Sales through Retail Pharmacies (Billion CAD),
2005-2008
- Figure 5-9: Share of Generic and Branded Drug Sales through Retail
Pharmacies (2005-2008)
- Figure 5-10: Branded Drug Sales through Hospital Pharmacies (Billion CAD),
2005-2008
- Figure 5-11: Generic Drug Sales through Hospital Pharmacies (Billion CAD),
2005-2008
- Figure 5-12: Share of Generic and Branded Drug Sales through Hospital
Pharmacies (2005-2008)
- Figure 5-13: Share of Independent Generic and Authorized Generic
Prescriptions (2002-2008)
- Figure 5-14: Generic Drug Market by Retail and Hospital Sales (%), 2008
- Figure 6-1: Cardiovascular Drug Market (Billion CAD), 2005-2008 & 2013
- Figure 6-2: Psychotherapeutics Market (Billion CAD), 2005-2008 & 2013
- Figure 6-3: Cholesterol Agents Market (Billion CAD), 2005-2008 & 2013
- Figure 6-4: Number of Diabetes Patients in Age Group 20-79 Years (' 000),
2003, 2008 & 2025
- Figure 6-5: Diabetes Therapy Market (Million CAD), 2005-2008 & 2013
- Figure 7-1: Forecast for Pharmaceutical Sales (Billion CAD), 2009-2013
- Figure 7-2: Forecast for Generic Drug Sales (Billion CAD), 2009-2013
- Figure 7-3: Forecast for Branded Drug Sales (Billion CAD), 2009-2013
- Figure 7-4: Forecast for Share of Branded and Generic Drugs by
Prescription (2009-2013)
- Figure 7-5: Forecast for Share of Branded and Generic Drugs by Sales
(2009-2013)
- Figure 7-6: Forecast for Contribution of Branded and Generic Drug Sales in
Growth of Pharmaceutical Market (%), 2009 to 2013
- Figure 8-1: Relation between Brand Sales and Number of Generic Entrants
List of Tables:
- Table 3-1: Top Ten Therapy Areas by Prescription (' 000), 2008
- Table 3-2: Top Ten Therapy Areas by Sales (' 000 CAD), 2008
- Table 3-3: Top Twenty Drugs in Pharmaceutical Market by Prescription
(Million), 2008
- Table 3-4: Top Ten Drugs in Pharmaceutical Market by Sales (Million CAD),
2007
- Table 4-1: Generic and Branded Drug Returns for Pharmacists (CAD)
- Table 5-1: Per Capita Drug Spending of Public and Private Sector by Region
(CAD), 2008
- Table 5-2: Generic Drug Prescriptions Dispensed by Region (%), 2002-2008
- Table 5-3: Generic Drug Sales by Region (%), 2004 & 2006
- Table 5-4: Number of Retail Pharmacies by Category (2002-2008)
- Table 5-5: Top Ten Therapy Areas by Hospital Sales (Million CAD), 2008
- Table 5-6: Pharmaceutical Sales by Distribution Channel (%), 2002-2006
- Table 8-1: Top Pharmaceutical Companies by Retail Prescription (Million),
2006
- Table 8-2: Ranking of Top Pharmaceutical Companies by Retail Prescription
(2004-2006)
- Table 8-3: Top Pharmaceutical Companies by Sales (Million CAD), 2008
- Table 8-4: Ranking of Top Pharmaceutical Companies by Sales (2006-2008)
- Table 8-5: Top Generic Drug Companies by Prescription (Million), 2007
- Table 8-6: Ranking of Top Generic Drug Companies by Prescription
(2005-2007)
- Table 8-7: Top Generic Drug Companies by Sales (Million CAD), 2007
- Table 8-8: Ranking of Top Generic Drug Companies by Sales (2005-2007)
- Table 8-9: Ranking of Top Generic Companies by Retail Sales (2007)
- Table 8-10: Ranking of Top Generic Companies by Hospital Sales (2006)
|
相關報告
|
